Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
The Journal of Rheumatology
|
April 1, 1983
Eosinophilic fasciitis--a new disease dilemma?
R Martin, J Strosberg, D Wexler
Endocrine-Related Cancer
|
November 8, 2018
Analysis of the immune landscape of small bowel neuroendocrine tumors
M Cives, J Strosberg, S Al Diffalha, et al.
Cancer Metastasis Reviews
|
January 24, 2014
Pancreatic NETs: where do we stand now?
S Faivre, D Castellano, J Strosberg, et al.
ESMO Open
|
January 1, 2022
Efficacy of ipilimumab and nivolumab in patients with high-grade neuroendocrine neoplasms
T Al-Toubah, T Halfdanarson, J Gile, et al.
ESMO Open
|
March 20, 2024
Phase II study of pembrolizumab and lenvatinib in advanced well-differentiated neuroendocrine tumors
T Al-Toubah, M J Schell, B Morse, et al.
Current Oncology (Toronto, Ont.)
|
March 12, 2016
Synchronous rectal adenocarcinoma and splenic marginal zone lymphoma
T Srikumar, M Markow, B Centeno, et al.
Endocrine-Related Cancer
|
August 25, 2016
Analysis of potential response predictors to capecitabine/temozolomide in metastatic pancreatic neuroendocrine tumors
M Cives, M Ghayouri, B Morse, et al.
Journal of Neuroendocrinology
|
February 13, 2025
NETest® 2.0-A decade of innovation in neuroendocrine tumor diagnostics
M Kidd, I A Drozdov, A Chirindel, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
The Journal of Rheumatology
|
April 1, 1983
Eosinophilic fasciitis--a new disease dilemma?
R Martin, J Strosberg, D Wexler
Endocrine-Related Cancer
|
November 8, 2018
Analysis of the immune landscape of small bowel neuroendocrine tumors
M Cives, J Strosberg, S Al Diffalha, et al.
Cancer Metastasis Reviews
|
January 24, 2014
Pancreatic NETs: where do we stand now?
S Faivre, D Castellano, J Strosberg, et al.
ESMO Open
|
January 1, 2022
Efficacy of ipilimumab and nivolumab in patients with high-grade neuroendocrine neoplasms
T Al-Toubah, T Halfdanarson, J Gile, et al.
ESMO Open
|
March 20, 2024
Phase II study of pembrolizumab and lenvatinib in advanced well-differentiated neuroendocrine tumors
T Al-Toubah, M J Schell, B Morse, et al.
Current Oncology (Toronto, Ont.)
|
March 12, 2016
Synchronous rectal adenocarcinoma and splenic marginal zone lymphoma
T Srikumar, M Markow, B Centeno, et al.
Endocrine-Related Cancer
|
August 25, 2016
Analysis of potential response predictors to capecitabine/temozolomide in metastatic pancreatic neuroendocrine tumors
M Cives, M Ghayouri, B Morse, et al.
Journal of Neuroendocrinology
|
February 13, 2025
NETest® 2.0-A decade of innovation in neuroendocrine tumor diagnostics
M Kidd, I A Drozdov, A Chirindel, et al.
Page
of 1